ScholarWorks@Gyeongsang National University

Browsing by Park, Yeon HeeAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 8 of 8

SCIESCOPUS
Multicenter study for brain metastasis from breast cancer in Korea: The significance of molecular subtype (Korean Radiation Oncology Group 1612).

Kim, In Ah; Kim, Jae Sik; Kim, Kyubo; Jung, Wonguen; Shin, Kyung Hwan; Im, Seock-Ah; Kim, Hee Jun; Kim, Yong Bae; Chang, Jee Suk; Kim, Jee Hyun, et al.

ArticleIssue Date2021CitationJournal of Clinical Oncology, v.39, no.15PublisherAmerican Society of Clinical Oncology
SCIESCOPUS
New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12)

Kim, Jae Sik; Kim, Kyubo; Jung, Wonguen; Shin, Kyung Hwan; Im, Seock-Ah; Kim, Hee-Jun; Kim, Yong Bae; Chang, Jee Suk; Kim, Jee Hyun; Choi, Doo Ho, et al.

ArticleIssue Date2021CitationBreast Cancer Research and Treatment, v.186, no.2, pp 453 - 462PublisherKluwer Academic Publishers
SCIESCOPUS
Novel prognostic classification predicts overall survival of patients receiving salvage whole-brain radiotherapy for recurrent brain metastasis from breast cancer: A recursive partitioning analysis (KROG 16-12)open access

Kim, Jae Sik; Kim, Kyubo; Jung, Wonguen; Shin, Kyung Hwan; Im, Seock-Ah; Kim, Yong Bae; Chang, Jee Suk; Choi, Doo Ho; Kim, Haeyoung; Park, Yeon Hee, et al.

ArticleIssue Date2021CitationBreast, v.60, pp 272 - 278PublisherChurchill Livingstone
SCIESCOPUS
Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma (R)) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+metastatic breast cancer (KCSG BR 18-14/KM10B)open access

Sim, Sung Hoon; Kim, Jeong Eun; Kim, Min Hwan; Park, Yeon Hee; Kim, Jee Hyun; Suh, Koung Jin; Koh, Su-Jin; Park, Kyong Hwa; Kang, Myoung Joo; Ahn, Mi Sun, et al.

ArticleIssue Date2022CitationBreast, v.65, pp 172 - 178PublisherChurchill Livingstone
SCIESCOPUSKCI
Prognostic Significance of a Complete Response on Breast MRI in Patients Who Received Neoadjuvant Chemotherapy According to the Molecular Subtypeopen access

Ko, Eun Sook; Han, Heon; Han, Boo-Kyung; Kim, Sun Mi; Kim, Rock Bum; Lee, Gyeong-Won; Park, Yeon Hee; Nam, Seok Jin

ArticleIssue Date2015CitationKOREAN JOURNAL OF RADIOLOGY, v.16, no.5, pp 986 - 995PublisherKOREAN RADIOLOGICAL SOC
SCIESCOPUS
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer (TNBC) with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21).

Park, In Hae; Kim, Gun Min; Kim, Jee Hyun; Kim, Hanjo; Park, Kyong Hwa; Park, Yeon Hee; Baek, Sun Kyung; Sim, Sung Hoon; Ahn, Hee Kyung; Lee, Gyeong-Won, et al.

ArticleIssue Date2020CitationJournal of Clinical Oncology, v.38, no.15PublisherAmerican Society of Clinical Oncology
SCIESCOPUS
Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16-12)open access

Kim, Jae Sik; Kim, Kyubo; Jung, Wonguen; Shin, Kyung Hwan; Im, Seock-Ah; Kim, Hee-Jun; Kim, Yong Bae; Chang, Jee Suk; Choi, Doo Ho; Park, Yeon Hee, et al.

ArticleIssue Date2020CitationBreast, v.49, pp 41 - 47PublisherChurchill Livingstone
SCIESCOPUS
Temporal patterns of chronic disease incidence after breast cancer: a nationwide population-based cohort studyopen access

Kang, Danbee; Kang, Minwoong; Hong, Yun Soo; Park, Jihwan; Lee, Jin; Seo, Hwa Jeong; Kim, Dong Wook; Ahn, Jin Seok; Park, Yeon Hee; Lee, Se Kyung, et al.

ArticleIssue Date2022CitationSCIENTIFIC REPORTS, v.12, no.1PublisherNATURE PORTFOLIO
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0533

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어